Plasma lipoproteins support prothrombinase and other procoagulant enzymatic complexes

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 18, Issue 3, 1998, Pages 458-465

  Moyer, Martin P ^a   Tracy, Russell P ^a   Tracy, Paula B ^a   Van't Veer, Cornelis ^a   Sparks, Charles E ^b   Mann, Kenneth G ^a  

^a UNIVERSITY OF VERMONT   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Blood coagulation; Lipoproteins; Prothrombinase; Thrombin

Indexed keywords

BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 5A; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PROCOAGULANT; PROTHROMBIN; PROTHROMBIN A; THROMBIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME KINETICS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID VESICLE; LIPOPROTEIN BLOOD LEVEL; PRIORITY JOURNAL; THROMBOCYTE;

EID: 0031893737     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.18.3.458     Document Type: Article

References (14)

1. Mann K, Nesheim M, Church W, Haley P, Krishnaswamy S. Surface dependent reactions of the vitamin K dependent enzyme complexes. Blood. 1990;76:1-16.
2. Nesheim M, Taswell J, Mann K. The contribution of bovine factor V and factor Va to the activity of prothrombinase. J Biol Chem. 1979;254:10952-10962.
3. Chandler A. An overview of thrombosis and platelet involvement in the development of the human atherosclerotic plaque. In: Glagov S, Newman W, Schaffe S, eds. Pathobiology of the Human Atherosclerotic Plaque. New. York, NY: Springer-Verlag; 1990:359-378.
4. White J. Anatomy and structural organization of the platelet. In: Coman R, Hirsh J, Marder V, Salzman E, eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice Philadelphia, Pa: JB Lippincott Co; 1994:397-413.
5. Tracy P, Allen D, Worfolk L, Robinson-Lawler R. Monocyte/macrophage regulation of coagulation events. Hemostasis. 1996;26(suppl 1):6-11.
6. Bouchard B, Catcher C, Thrash B, Adida C, Tracy P. Effector cell protease receptor-1, a platelet activation-dependent membrane protein, regulates prothrombinase-catalyzed thrombin generation. J Biol Chem. In press.
7. Bouchard B, Shatos M, Tracy P. Human brain pericytes differentially regulate expression of procoagulant enzyme complexes comprising the extrinsic pathway of blood coagulation. Arterioscler Thromb Vasc Biol. 1997;17:1-9.
8. Gotto A, Farmer J. Risk factors for coronary artery disease and their management. In: Braunwald E, ed. Heart Disease: A Textbook of Cardiovascular Medicine. Philadelphia, Pa: WB Saunders Co; 1988:1153-1187.
9. National Heart, Lung, and Blood Institute. National Heart, Lung, and Blood Institute consensus development panel: treatment of hypertriglyceridemia. JAMA. 1984;251:1196-1200.
10. Austin M. Epidemiologic associations between hypertriglyceridemia and coronary heart disease. Sem Thromb Hemost. 1988;14:137-142.
11. Menotti A, Scanga M, Morisi G. Serum triglycerides in the prediction of coronary artery disease. Am J Cardiol. 1994;73:29-32.
12. Mann K. Factor VII assays, plasma triglyceride levels and cardiovascular disease risk. Arteriosclerosis. 1989;9:783-784.
13. Schaeffer E, McNamara J, Genest J, Ordovas J. Clinical significance of hypertriglyceridemia. Semin Thromb Hemost. 1988;14:143-148.
14. Miller G, Martin J, Mitropoulos K, Reeves B, Thompson R, Meade T, Cooper J, Cruickshank J. Plasma factor VII is activated by postprandial triglyceridemia, irrespective of dietary fat composition. Atherosclerosis. 1991;86:163-171.